Gunung Raja Paksi Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Gunung Raja Paksi Tbk. trades at Rp302 (market cap 3.68T, 218.2K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume). The key difference: Gunung Raja Paksi Tbk. is far larger — about 7.8× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 218.2K). Which is the better fit depends on your goals.
| GGRP | PRDL | |
|---|---|---|
Market Cap | 3.68T | 470.58B |
Volume | 218.2K | 18.86M |
Lot | 2.18K | 188.57K |
Turnover | 65.68M | 4.97B |
Average Price | 301 | 263.63 |
Value | 65.68M | 4.97B |
Indicative Equilibrium Price | 304 | 264 |
Indicative Equilibrium Volume | 2K | 3.64K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →